Tianda Pharmaceuticals Limited provided earnings guidance for the year ended 31 March 2019. For the period, the company expects to record a significant decline in the profit attributable to owners of the parent for the Current Financial Year as compared with the profit attributable to owners of the parent of approximately HKD 10 million for the year ended 31 March 2018.